Predictors and Variation in Cardiac Rehabilitation Participation After Transcatheter Aortic Valve Replacement

Devraj Sukul1,2,3, Jeremy Albright1, Michael P Thompson3,4,5

  • 1Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.

JACC. Advances
|June 28, 2024
PubMed

Insights

Less than one-third of patients undergoing transcatheter aortic valve replacement (TAVR) participate in cardiac rehabilitation (CR) within 90 days. Hospital variation in CR participation is significant and not explained by patient factors, highlighting the need to identify effective hospital processes.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Cardiac rehabilitation (CR) is a crucial component of post-procedural care for patients with cardiovascular conditions.
  • Aortic valve replacement, including transcatheter aortic valve replacement (TAVR), is a common procedure for which CR is recommended.
  • Understanding CR participation rates and associated factors is vital for optimizing patient recovery and outcomes after TAVR.

Purpose of the Study:

  • To investigate patient and hospital-level factors influencing CR participation following TAVR.
  • To quantify the variation in CR participation rates across different hospitals.
  • To determine if patient case mix explains the observed hospital-level disparities in CR enrollment.

Main Methods:

  • A retrospective analysis linked clinical and administrative claims data for 3,372 patients who underwent TAVR.
  • Data were collected from 24 hospitals in Michigan between January 2016 and June 2020.
  • Sequential mixed-effects models were used to assess hospital variation in CR participation within 90 days of discharge.

Main Results:

  • Only 30.6% of TAVR patients enrolled in CR within 90 days post-discharge.
  • Factors negatively associated with CR participation included older age, Medicaid insurance, atrial fibrillation, dialysis, and slower walking speed.
  • Significant hospital variation in CR participation was observed (5% to 60%), which was not explained by patient case mix.

Conclusions:

  • Post-TAVR CR participation remains low, with substantial unexplained variation across hospitals.
  • Patient characteristics alone do not account for differences in CR enrollment rates between facilities.
  • Identifying and implementing effective hospital-based strategies is essential to improve CR uptake after TAVR.
Abstract

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...